Видео ютуба по тегу Alon Ben-Noon

Alon Ben-Noon of NeuroSense Therapeutics
Alon Ben-Noon of NeuroSense Therapeutics
Phase 2b Study Readouts - Shifting the PARADIGM by Mr.Alon Ben-Noon
Phase 2b Study Readouts - Shifting the PARADIGM by Mr.Alon Ben-Noon
NRSN - Opening Bell Ceremony's Remarks by Alon Ben-Noon
NRSN - Opening Bell Ceremony's Remarks by Alon Ben-Noon
Interview with Alon Ben Noon CEO, NeuroSense TX
Interview with Alon Ben Noon CEO, NeuroSense TX
Impossible Dreams, ALS Journey & Breakthroughs
Impossible Dreams, ALS Journey & Breakthroughs
Episode 6: Alon Ben-Noon of NeuroSense Therapeutics
Episode 6: Alon Ben-Noon of NeuroSense Therapeutics
ALS Therapies and Treatment Updates: Updates on PrimeC by Mr.Alon Ben-Noon
ALS Therapies and Treatment Updates: Updates on PrimeC by Mr.Alon Ben-Noon
Clinical trial opens enrollment: shifting the PARADIGM with PrimeC by Alon Ben-Noon
Clinical trial opens enrollment: shifting the PARADIGM with PrimeC by Alon Ben-Noon
NeuroSense Therapeutics Reports Positive Results from Stage III ALS Biomarker Study
NeuroSense Therapeutics Reports Positive Results from Stage III ALS Biomarker Study
NeuroSense CEO Update Video Q1 2022
NeuroSense CEO Update Video Q1 2022
NeuroSense CEO Update Video Q2 2022
NeuroSense CEO Update Video Q2 2022
NeuroSense CEO Update Video Q2 2023
NeuroSense CEO Update Video Q2 2023
Do You Remember? 💜 $NRSN for Alzheimer’s
Do You Remember? 💜 $NRSN for Alzheimer’s
NRSN 4 ALS
NRSN 4 ALS
NeuroSense Therapeutics, Ltd. (NASDAQ: NRSN)
NeuroSense Therapeutics, Ltd. (NASDAQ: NRSN)
NeuroSense CEO Recaps 2022 Achievements & Presents 2023 Catalysts
NeuroSense CEO Recaps 2022 Achievements & Presents 2023 Catalysts
NeuroSense Therapeutics - Study of New Drug to Treat ALS
NeuroSense Therapeutics - Study of New Drug to Treat ALS
Innovation Israel - NeuroSense new drug may offer hope to ALS patients
Innovation Israel - NeuroSense new drug may offer hope to ALS patients
NRSN - BIO CEO Conference - Presentation Preview
NRSN - BIO CEO Conference - Presentation Preview